Halozyme Therapeutics, Inc. (HALO)
70.16
+0.76
(+1.10%)
USD |
NASDAQ |
Mar 04, 14:10
Halozyme Therapeutics Price : 70.16 for March 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 120.36 |
| Johnson & Johnson | 244.91 |
| Skye Bioscience, Inc. | 0.7532 |
| AIM ImmunoTech, Inc. | 0.70 |
| Stryker Corp. | 383.28 |
Price Related Metrics
| PE Ratio | 28.16 |
| PS Ratio | 6.164 |
| Price to Book Value | 169.63 |
| Price to Free Cash Flow | 13.36 |
| Earnings Yield | 3.55% |
| Market Cap | 8.280B |
| Operating PE Ratio | 10.55 |
| Normalized PE Ratio | 15.28 |